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Amino-4-imidazolecarboxamide ribotide (AICAR) is an intermediate in the de novo purine biosynthetic pathway and its accumulation impacts a variety of metabolic processes in a number of organisms such as Salmonella enterica (3) (4) (5) (6) , Escherichia coli (8) , Saccharomyces cerevisiae (9) , and humans (11) . AICAR is also generated as a by-product during histidine biosynthesis and recycled by subsequent entry into the purine biosynthetic pathway in organisms that synthesize histidine ( Fig. 1) (12) (13) (14) . Much of the work defining the consequences of AICAR accumulation has been in eukaryotic cell lines, where AICAR has been associated with disease treatments, such as methotrexate, and has shown therapeutic potential with regard to carbohydrate and lipid metabolism (15) (16) (17) (18) (19) and tumor cell proliferation (20, 21) . In bacteria, AICAR is linked to metabolic disturbances in thiamine biosynthesis (3) (4) (5) , gluconeogenesis (6) , and purine metabolism (8) . In cases where it has been characterized, the mechanism of AICAR action is conserved between humans and bacteria, a finding that emphasizes the value of understanding the diverse targets of AICAR in a bacterial system.
Phosphoribosylaminoimidazolecarboxamide formyltransferase/ IMP cyclohydrolase (PurH, EC 2.1.2.3/3.5.4.10) is the bifunctional enzyme that catalyzes the last two steps in purine biosynthesis and uses AICAR as a substrate (Fig. 1) . S. enterica strains lacking PurH accumulate AICAR and have a requirement for exogenous thiamine (3) (4) (5) . Thiamine pyrophosphate (TPP) is an essential coenzyme required for central metabolic enzymes such as pyruvate dehydrogenase (EC 1.2.4.1), ␣-ketoglutarate dehydrogenase (EC 1.2.4.2), and transketolase (EC 2.2.1.1). TPP is synthesized by convergent pathways, each of which generates a ringed moiety: either 4-methyl-5-(␤-hydroxyethyl)-thiazole (THZ) monophosphate or 4-amino-5-hydroxymethyl-2-methylpyrimidine (HMP) pyrophosphate. The THZ and HMP moieties are then condensed to form thiamine monophosphate, which is phosphorylated to the coenzymic form, TPP (22) . The first five steps of the HMP biosynthetic pathway are common to the purine biosynthetic pathway.
Despite the fact that PurH functions beyond the branchpoint to HMP synthesis, purH mutants require the HMP moiety of thiamine (3) (4) (5) 14) . Previous studies showed the requirement for HMP was caused by accumulated AICAR and due to a constraint in the conversion of amidoimidazole ribotide (AIR) to HMP (14) . AIR is converted to HMP by the S-adenosylmethionine radical protein ThiC (23, 24) . In vivo, decreased coenzyme A (CoA) levels result in lowered ThiC activity (14, 25 ) and yet, in vitro, ThiC activity does not require-and is not improved by-the addition of CoA to the reaction (26) .
CoA is a universally required coenzyme and an important carrier molecule that has a pivotal role in metabolic processes such as fatty acid oxidation and synthesis, the tricarboxylic acid cycle, and amino acid biosynthesis. CoA is composed of AMP and 4=-phosphopantetheine moieties. The 4=-phosphopantetheine moiety is synthesized from pathways that converge at pantoate ␤-alanine ligase (PanC, EC 6.3.2.1), which generates pantothenate (Fig. 1) . Subsequent reactions convert pantothenate to 4=-phosphopantetheine, which is then adenylated by ATP and lastly phosphorylated to generate CoA.
We show here that accumulation of AICAR decreased the cellular pool size of CoA in S. enterica and identify pantoate ␤-alanine ligase as the target of this effect. The data showed that the thiamine requirement of a purH mutant was at least partially modulated by the resulting decrease in CoA levels. These findings show that a consequence of accumulating the metabolite AICAR is the disruption of CoA biosynthesis, thus impacting a central component in all metabolisms.
MATERIALS AND METHODS
Bacterial strains, media, and chemicals. Strains used in the present study are derivatives of S. enterica serovar Typhimurium LT2 and are described in Table 1 . Rich (NB) medium was made with Difco nutrient broth (8 g/liter) and NaCl (5 g/liter). Super broth (SB) was used for protein overexpression. Defined medium was no carbon E medium (NCE) supplemented with 1 mM MgSO 4 (27) (28) (29) trace minerals (30) and 11 mM glucose (or 20 mM ribose) as a sole carbon source. Alternatively, the defined medium contained 1 mM glutamine (instead of NaNH 4 PO 4 ) as a limiting ammonium nitrogen source (31, 32) . Difco BiTek agar (15 g/liter) was added for solid medium. When present in the media, compounds were at the following final concentrations: adenine (0.4 mM), pantothenate (0.1 mM), histidine (0.1 mM), thiamine (100 nM), ketoisovalerate (0.5 mM), ketopantoate (0.1 mM), pantoate (0.1 mM), ␤-alanine (0.1 mM), and aspartate (0.3 mM). Antiobiotics were used at the following concentrations for rich (minimal) medium, respectively: tetracycline, 20 g/ml (10 g/ml); kanamycin, 50 g/ml (150 g/ml); chloramphenicol, 20 g/ml (5 g/ml); and ampicillin, 100 g/ml (15 g/ml).
Growth quantitation. Cell cultures grown overnight in NB medium were pelleted and resuspended in an equal volume of saline (0.85% NaCl). A 0.1-ml aliquot was used to inoculate 5 ml of the appropriate minimal medium. When the growth was quantified in a microplate reader (model EL808; Bio-Tek Instruments), a 5-l inoculum was used for 195 l of the appropriate minimal medium. Unless otherwise stated, cell density was measured as absorbance at 650 nm, and growth was routinely reported as specific growth rates [ ϭ ln(X/X 0 )/T] or the final cell optical density at 650 nm (OD 650 ) reached after 12 to 24 h of incubation at 37°C with shaking (33) . When nutritional requirements were measured on solid medium, soft agar overlays were used as has been described (14) .
Genetic techniques. (i) General. Transductional crosses were done with a high-frequency general transducing mutant of bacteriophage P22 (HT105/1, int-201) (34) . Methods for transductional crosses, isolation of transductants from phage, and identification of phage-free transductants have been previously described (35, 36) . Mutant strains were constructed using standard genetic techniques.
(ii) Isolation of suppressor mutations. Multiple cultures of DM2 (purH355) were grown overnight in NB medium. Cells were pelleted and resuspended in an equal volume of saline. A 0.1-ml aliquot (ϳ10 8 cells) was spread on solid glucose medium with adenine (28) . After incubation at 37°C for 48 to 72 h, colonies that arose were streaked for isolation on nonselective rich medium and were further characterized. To ensure genetic independence, only one colony from each plate was pursued.
Cloning panC. The panC gene was amplified from wild-type S. enterica (DM10000). The primers were flanked by EcoRI (forward) and XhoI (reverse) restriction sequences. The blunt-ended amplicon was cloned with the StrataClone Blunt PCR cloning kit (Agilent Technologies). The vectors from transformants were isolated and screened for the panC insertion. The panC insertion was excised with EcoRI and XhoI and subcloned into pET-20b(ϩ) digested with the same restriction enzymes.
Purification of PanC. A 50 ml overnight culture (at room temperature with shaking) of BL21-AI (transformed with pET20b-panC) in SB sup- plemented with 150 g of ampicillin/ml was used to inoculate two flasks (each with 1.5 liter) of the same medium. Arabinose was added to 0.2% when the OD 650 reached 0.5, and incubation continued for 12 h at room temperature prior to harvesting the cells by centrifugation (7,000 ϫ g for 10 min at 4°C). The cell pellet was resuspended in binding buffer (50 mM KPO 4 [pH 7.5], 100 mM KCl, 5% glycerol). DNase and lysozyme were added at 0.01 mg/ml, cells were broken with a French pressure cell press (three passes at 1,500 lb/in 2 ), and cell debris was pelleted by centrifugation (18,000 ϫ g for 45 min at 4°C). Lysate was passed through a 0.22-mpore-size filter and loaded onto Ni-NTA SuperFlow resin (Qiagen). Five column volumes (CV) of binding buffer, followed by 15 CV of binding buffer containing 15 mM imidazole, were passed over the column until the absorbance at 280 nm of the eluent was zero. PanC was eluted with ϳ100 mM imidazole when a gradient (15 to 500 mM imidazole) was applied over 20 CV (200 ml). PanC concentration was determined using the bicinchoninic acid assay (Pierce). TotalLab Quant software was used to determine that the protein purity was Ͼ99%.
PanC activity assays. (i) General. PanC activity was assayed by modifying a previously described method where AMP formation is coupled to myokinase and lactic dehydrogenase activities (37, 38) . Ultimately, two molecules of NADH were oxidized per molecule of pantothenate formed. Final reaction volumes were 200 l and contained the following: 100 mM Tris (pH 7.5), 10 mM MgCl 2 , 0.3 mM NADH, 2.5 mM ATP, 1.5 mM phosphoenolpyruvate, 3 mM ␤-alanine, 4 mM pantoate, 50 U of pyruvate kinase/ml, 55 U of lactate dehydrogenase/ml, 25 U of myokinase/ml, and 50 nM PanC. The oxidation of NADH was monitored at 340 nm in a microplate reader (SpectraMax Plus; Molecular Devices). The linear equation of an NADH standard curve was generated and used to convert absorbance to the appropriate units. The data were fit to the MichaelisMenten model in GraphPad Prism version 6.0b.
(ii) Inhibition studies. A screen of potential inhibitors of PanC (AICAR, AICARs, or AIC) was performed by their inclusion in the reaction mixtures at 3 and 5 mM. Reactions were initiated by the addition of pantoate (40 l). Inhibition of PanC by AICAR was further characterized using five AICAR concentrations (0 to 16 mM) at various concentrations of pantoate (0 to 16 mM), ␤-alanine (0 to 8 mM), and ATP (0 to 4 mM). Reactions to address inhibition by AICAR were initiated by the addition of the substrate that was being varied and ATP (52 to 85 l). LineweaverBurk plots were used to determine the form of inhibition for each substrate. Substrate-velocity data were then fit to the corresponding inhibition models (GraphPad Prism version 6.0b) to determine K i values. Each fit was constrained by experimentally derived K m values for the relevant substrate: pantoate (1.39 mM), ␤-alanine (0.66 mM), and ATP (1.62 mM).
Total CoA measurements. Biological triplicates of relevant strains were grown to an OD 650 of ϳ0.5 in 200 ml of minimal glucose (16.5 mM) medium containing adenine and thiamine with or without 0.1 mM histidine. Total cellular CoA pools were quantitated by a previously described method (39) . NADH formation was monitored at 340 nm in a traditional UV/Vis spectrometer (Lambda Bio 40; Perkin-Elmer Instruments) or in a microplate reader (SpectraMax Plus).
␤-Galactosidase assays. Biological triplicates of DM308 (panC607:: MudJ), DM309 (panC607::MudJ panB614::Tn10d(Tc), and purH isogenic strains DM14375 (purH355 panC607::MudJ) and DM14376 (panC607::MudJ) were grown to an OD 650 of between 0.4 and 0.5 in 5 ml of minimal glucose medium containing adenine, pantothenate, and thiamine with or without 0.1 mM histidine. The ␤-galactosidase activity of each sample was quantitated by a previously described method (40-42). 2-Nitrophenol formation was monitored at 420 nm in a microplate reader (SpectraMax Plus) for 60 min. The rates of product formation were determined as (⌬A 420 /min)/OD 650 .
RESULTS
AICAIR inhibits multiple pathways important for HMP synthesis. DM2 (purH355) is a representative purH mutant strain with a previously described frameshift mutation that eliminates all PurH activity in the cell (6) . DM2 and other purH mutants of S. enterica required exogenous addition of the HMP moiety of thiamine to grow in glucose medium with adenine (3) (4) (5) . The data in Fig. 2 show the nutritional additions that partially or fully eliminate the need for exogenous thiamine. These data confirmed previous ob- a All strains are S. enterica serovar Typhimurium LT2 and were part of the lab collection or were constructed for this study. b Tn10d(Tc) refers to the transposition-defective mini-Tn10 (Tn10⌬16⌬17) construct (7) . MudJ refers to the MudJ1734 transposon (10).
FIG 2
Pantothenate and methionine additively restore thiamine-independent growth of a purH mutant. The growth of a purH mutant was quantified in minimal medium containing glucose and adenine with no addition (), methionine (OE), pantothenate (), methionine and pantothenate (}), histidine (), and thiamine (OE).
servations that histidine, methionine and pantothenate each individually restored growth (5, 12) (43) and showed that methionine and pantothenate were additive in their effect. Because exogenous histidine lowers AICAR in the cell (5, 12, 14) , these data emphasized that AICAR accumulation was the metabolic imbalance that caused a thiamine requirement and that more than one metabolic pathway was disrupted by this accumulation. The stimulatory effect of exogenous pantothenate suggested an involvement of CoA levels in the growth phenotype (Fig. 1) .
CoA levels are decreased in a purH mutant. The reported link between CoA levels and ThiC activity (14) in combination with the results above suggested that the accumulation of AICAR negatively impacted CoA biosynthesis. The total CoA was quantified in wild-type and purH mutant strains and the data are shown in Table 2 . Significantly, in glucose adenine medium where the strain requires exogenous thiamine, the purH mutant had total CoA levels 3-fold lower than the wild-type strain. Furthermore, addition of exogenous histidine restored wild-type levels of CoA by reducing the formation of AICAR, which eliminated the requirement for exogenous thiamine. These results established an inverse correlation between AICAR accumulation and CoA levels in the cell. With the knowledge that decreased CoA levels cause reduced ThiC activity, these data supported the hypothesis that AICAR inhibits HMP synthesis by lowering cellular CoA pools.
Pantothenate biosynthesis is compromised in a purH mutant. The stimulation of thiamine-independent growth in a purH mutant by pantothenate was consistent with a constraint in CoA biosynthesis that was prior to the formation of pantothenate. Pantothenate is formed by the condensation of two separately synthesized moieties, pantoate, and ␤-alanine. Each moiety was provided as a supplement, and thiamine-independent growth of DM2 was quantified in liquid media. The data in Fig. 3 showed that when both pantoate and ␤-alanine were present, growth was restored to the level allowed by the addition of pantothenate. The requirement for both pantoate and ␤-alanine suggested that either AICAR inhibited biosynthesis of both moieties or that the PanC reaction was compromised. Further nutritional studies showed that providing both ketoisovalerate and aspartate to minimal glucose adenine medium allowed thiamine-independent growth of DM2 ( ϭ 0.28), suggesting that the biosynthetic enzymes upstream of PanC were not compromised.
When panC was provided in trans (pET20b-panC) under the control of a constitutive promoter, thiamine-independent growth of the purH mutant was not restored (data not shown). Importantly, pET20b-panC was able to complement a panC355 mutant (DM3) in minimal glucose adenine medium. The expression of the panBCD operon was quantitated by ␤-galactosidase assays with strains containing panC607::MudJ in the chromosome. The rate of ␤-galactosidase product formation in DM14375 [purH355, (0.846 ⌬A 420 /min)/OD 650 ] was comparable to the isogenic strain DM14376 [0.688 (⌬A 420 /min)/OD 650 ]. These results eliminated scenarios in which AICAR decreased gene expression of the pan operon or the panC gene specifically.
AICAR inhibits the PanC reaction.
A number of enzymes are inhibited allosterically by AICAR, including several that bind adenosine (11) or ATP (6) . Based on this precedent and the involvement of ATP in the PanC reaction mechanism, it was plausible that PanC was directly inhibited by AICAR. PanC was purified and assayed in vitro with or without AICAR and its derivatives. AICAR inhibited the PanC reaction when provided in concentrations similar to that of the substrates, reducing activity by ϳ3-fold (Table 3 ). The AICAR riboside (AICARs) reduced PanC activity by ϳ 1.5-fold, whereas AIC, the free base of AICAR, did not have any significant effect on the reaction. Inhibition by AICAR was probed further and found to be noncompetitive with pantoate (K i ϭ 5.7 mM), uncompetitive with ␤-alanine (K i = ϭ 4.1 mM), and competitive with respect to ATP (K i ϭ 1.8 mM). These data are shown in Fig. 4 and were consistent with previous reports of the kinetic mechanism of E. coli PanC (38, 44) . These in vitro data supported the hypothesis that when AICAR (and/or its riboside) accumulate, CoA levels are reduced in vivo due to a direct inhibition of the PanC-catalyzed reaction.
Suppressor analyses implicate CoA levels as source of HMP requirement. In vivo suppressor analyses were initiated to dissect the role of CoA in the AIR to HMP conversion. Specifically, we 
FIG 3
Pantoate and ␤-alanine restore endogenous HMP biosynthesis in a purH mutant. The growth of a purH mutant was quantified in minimal medium containing glucose and adenine with pantoate (OE), ␤-alanine (OE), pantoate and ␤-alanine (), and pantothenate (o). sought to identify mutations that allowed thiamine synthesis despite low CoA levels. Forty independent spontaneous mutations that allowed a purH to grow on glucose adenine medium were characterized and assigned to one of three classes (Fig. 5A) . Mutations in panR (the promoter region of the 3 min. panBCD operon) that restored thiamine-independent growth to a purH mutant have been previously described (45) . To identify panR mutations among the new suppressor strains, the strains were screened for an ability to feed a pantothenate auxotroph [DM3547; panC:: Tn10d(Tc)]. Of the 40 isolates, 29 (Ͼ70%) contained a panR mutation based on this assay. A representative seven of these strains were tested to confirm the location of the mutations. In each case the causative mutation was cotransducible with a characterized insertion (zae3653::Tn10) near the panBCD locus. Sequence analysis determined six of the seven strains carried the same base addition that was previously shown to increase transcription of the pan operon (46) . The seventh strain carried a transition (C-to-T) mutation two base pairs upstream of the transcription start site for panBCD (46) . Although not further characterized, this mutation brought the promoter sequence closer to consensus and was thus expected to increase transcription of the pan operon. This class of mutations allowed thiamine synthesis by restoring CoA levels.
The remaining 11 revertant strains were screened for the ability to utilize succinate. Loss-of-function mutations in sdh (encoding succinate dehydrogenase) restore thiamine-independent growth to a variety of strains with compromised thiamine biosynthesis by lowering the cellular thiamine requirement (47) . Eight of the eleven strains were unable to utilize succinate, leaving three purH revertants (DM8384, DM8388, and DM8397) that were not in a previously described class.
Increased AIR formation bypasses reduced CoA in HMP synthesis. Genetic analysis of the remaining three mutations placed them in the trp operon and sequence analysis identified each of the mutations in trpC ( Table 4 ). The relevant trpC alleles were recessive, the protein variants retained sufficient activity to allow tryptophan synthesis for growth, and a role for biosynthetic flux was indicated by the negative effect of tryptophan addition (Fig. 5B) . The data above were reminiscent of similar trpC alleles that restored the synthesis of the thiamine intermediate phosphoribosyl- amine (PRA) by the accumulation and subsequent breakdown of phosphoribosylanthranilate (PR-Ant) (48) . The PR-Ant breakdown product, ribose-5-phosphate, and ammonium nonenzymatically combine to form PRA (Fig. 6 ). Nonenzymatic PRA formation is elevated when ribose is the sole carbon source and decreased in limiting ammonium medium (32, 48, 49) . Nutritional studies showed that while minimal NCE glucose adenine medium allowed thiamine-independent growth of the purH trpC mutant ( ϭ 0.27), limiting ammonium glucose medium did not ( Ͻ 0.02). Importantly, the addition of thiamine restored growth of the purH trpC mutant in limiting ammonium medium ( ϭ 0.25). In addition, the purH mutant gained the ability to grow independent of thiamine in minimal NCE medium containing adenine when ribose was the sole carbon source ( ϭ 0.23). Taken together, these data suggested that increased PRA/ AIR formation (via the trpC alleles or ribose) suppressed the thiamine requirement of a purH mutant and allowed HMP synthesis in the presence of reduced CoA levels. The desired class of mutants that impacted the need for CoA in the conversion of AIR to HMP was not identified in the present study.
DISCUSSION
AICAR accumulates in a purH mutant and inhibits the conversion of AIR to HMP, a step catalyzed by the SAM radical protein ThiC (14) . The ThiC reaction has been reconstituted in vitro and is not affected by AICAR, indicating the effect in vivo was indirect (26) . The present study was initiated to determine the mechanism by which AICAR accumulation inhibits the conversion of AIR to HMP.
The ThiC reaction uses SAM as a cosubstrate and is sensitive to fluctuations in CoA levels in vivo (14, 23, 24, 50) . Nutritional studies led to the hypothesis that one metabolic consequence of AICAR accumulation was decreased CoA levels. Metabolite pool measurements confirmed that strains that accumulated AICAR had ϳ3-fold-lower total CoA levels than the wild type. Although this level of CoA reduction does not generate a thiamine requirement in an otherwise wild-type strain, conditions that reduce flux through the purine biosynthetic pathway (i.e., adenine in the medium) increase the CoA requirement for thiamine synthesis (25) .
Further nutritional studies suggested that the step in pantothenate synthesis catalyzed by PanC was compromised in a purH mutant. In vitro, both AICAR and its riboside inhibited PanC activity. The K i of 1.8 mM (AICAR) measured for competitive inhibition with respect to ATP is consistent with this effect being physiologically relevant. Previous studies with E. coli used the antifolate trimethoprim to inhibit the AICAR transformylase activity of PurH and measure the accumulation of AICAR metabolites. These data showed that in 60 min the intracellular AICAR levels rose to 0.8 mM and the AICAR triphosphate rose to 0.5 mM (51). Earlier work with numerous S. enterica purH mutants noted that AICARs was the primary AICAR-related metabolite to accumulate (43) . These data together suggested that AICAR and AICARs could inhibit PanC in vivo, which would reduce pantothenate and consequently CoA production in a purH mutant.
Suppressor mutation analysis of the purH mutant emphasized the correlation between reduced CoA and a requirement for thiamine, since deregulating pantothenate biosynthesis restored thiamine-independent growth. Further, decreasing AICAR synthesis with exogenous histidine restored both CoA levels and thiamine synthesis. Other suppressor mutations were consistent with previous work that characterized robustness in the formation of PRA and described the thiamine sparing effect of a strain lacking succinate dehydrogenase. A desired class of mutations that could provide insights into the mechanism that is used by CoA to impact the conversion of AIR to HMP was not found in the present study and will require refined genetic screens.
Dissecting the biochemical mechanism(s) responsible for diverse phenotypes in bacteria has repeatedly unveiled paradigms of metabolism that are conserved through a multitude of organisms. The present study followed a phenotype based in thiamine synthesis and led to the demonstration that CoA levels can be modulated by AICAR (and its riboside), a metabolite that accumulates after various cellular perturbations in a number of organisms. The results presented here have provided new insights into how CoA biosynthesis is integrated into the metabolic network. Beyond the impact on CoA biosynthesis, these results suggest that the thiamine requirement of a purH mutant can be used to define perturbation in other metabolic processes that result from the accumulation of AICAR in Salmonella. Studies such as those here will continue to define the metabolic network in bacteria and contribute to the understanding of metabolic paradigms that will facilitate efforts to manipulate metabolism in a diverse organisms.
